A rare kind of antibody, known as anti-glutamic acid decarboxylase (GAD) autoantibody, is
found in some patients. The antibody works against the GAD enzyme, which is essential in …

A number of neurological syndromes have been described in patients with positive serum
antibodies (Abs) against the enzyme glutamic acid decarboxylase (GAD), the rate limiting …

Antibodies against glutamic acid decarboxylase (GAD) are associated with various
neurologic conditions described in patients including stiff person syndrome, cerebellar …

We reported a patient with immune-mediated encephalopathy showing refractory epilepsy
and multiple brain lesions on MRI. The patient had high titers of anti-glutamic acid …

The association of high levels of autoantibodies to glutamic acid decarboxylase (GAD-ab)
and stiff-person syndrome (SPS) is well known. However, the full spectrum of neurological …

High prevalence of autoantibodies against glutamic acid decarboxylase (GAD-Ab) in stiff
man syndrome (SMS) not only helps diagnosis, but also suggests immune mediated …

Several neurological syndromes have been recognized associated to GAD antibodies.
Among those disorders, cerebellar ataxia (CA) is one of the most common, along with stiff …

Glutamic acid decarboxylase (GAD) catalyzes the conversion of glutamic acid to γ‐
aminobutyric acid (GABA). Autoantibodies directed against GAD (antiGAD‐Ab) have been …

DISCUSSION GAD is the enzyme that catalyses the conversion of glutamic acid to the
neurotransmitter gamma-amino butyric acid. Neurological disorders related to GAD …

Antibodies to glutamic acid decarboxylase (GADAb) are found in Stiff‐Person syndrome,
type 1 diabetes, cerebellar ataxia and other neurological disorders (such as epilepsy and …